Cutaneous vasculitis after COVID-19 vaccination in a 41-year-old male

Mehran Pournazari; Shirin Assar; Faraneh Farsad; Dena Mohamadzadeh

doi:10.1002/ccr3.7238

Cutaneous vasculitis after COVID-19 vaccination in a 41-year-old male

Clin Case Rep. 2023 Apr 22;11(4):e7238. doi: 10.1002/ccr3.7238. eCollection 2023 Apr.

Authors

Mehran Pournazari¹, Shirin Assar¹, Faraneh Farsad², Dena Mohamadzadeh¹

Affiliations

¹ Clinical Research Development Center Imam Reza Hospital, Kermanshah University of Medical Sciences Kermanshah Iran.
² Research Centre of Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.

Abstract

Leukocytoclastic vasculitis could be a possible adverse event of different SARS-CoV-2 vaccines. Clinicians and manufacturers should be aware of this adverse event for appropriate diagnosis and treatment.

Keywords: COVID‐19 infection; SARS‐CoV‐2 vaccine; cutaneous vasculitis; leukocytoclastic vasculitis.

Publication types

Case Reports